These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Semaphorins in cancer. Neufeld G, Shraga-Heled N, Lange T, Guttmann-Raviv N, Herzog Y, Kessler O. Front Biosci; 2005 Jan 01; 10():751-60. PubMed ID: 15569615 [Abstract] [Full Text] [Related]
27. A role for class 3 semaphorins in prostate cancer. Blanc V, Nariculam J, Munson P, Freeman A, Klocker H, Masters J, Williamson M. Prostate; 2011 May 01; 71(6):649-58. PubMed ID: 20949546 [Abstract] [Full Text] [Related]
28. The role of semaphorins and their receptors in vascular development and cancer. Gu C, Giraudo E. Exp Cell Res; 2013 May 15; 319(9):1306-16. PubMed ID: 23422037 [Abstract] [Full Text] [Related]
29. Plexins: axon guidance and signal transduction. Negishi M, Oinuma I, Katoh H. Cell Mol Life Sci; 2005 Jun 15; 62(12):1363-71. PubMed ID: 15818466 [Abstract] [Full Text] [Related]
30. Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Rieger J, Wick W, Weller M. Glia; 2003 Jun 15; 42(4):379-89. PubMed ID: 12730958 [Abstract] [Full Text] [Related]
36. Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression. Toledano S, Nir-Zvi I, Engelman R, Kessler O, Neufeld G. Int J Mol Sci; 2019 Jan 28; 20(3):. PubMed ID: 30696103 [Abstract] [Full Text] [Related]